South Korea's Economy Minister Pledges Support for Local Biosimilar Companies
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Emphasizing the importance of biosimilars for the country's economic growth potential in coming years, Knowledge Economy Minister Choi Kyung-Hwan - one of South Korea's top economic leaders - assured industry that the ministry will help local pharmaceutical outfits lay a solid foundation for the burgeoning biosimilar sector
You may also be interested in...
New Pricing System Could Deal A Blow To South Korea's Generic-Dependent Companies
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices
New Pricing System Could Deal A Blow To South Korea's Generic-Dependent Companies
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices
Korean Government Announces Joint Fund To Beef Up Local Pharma Industry
SEOUL - The Korean government is moving to create a KRW2 trillion ($1.7 billion) research and development fund to help local Korean pharma companies develop globally competitive new drugs